Artificial intelligence has already demonstrated great promise in many aspects of biomedical research, from accelerating scientific discovery to speeding the translation of biological insights into new therapies. Scripps Research today announced it has received a significant award of in-kind compute power from the Jen-Hsun and Lori Huang Foundation to advance the adoption of AI into biomedicine and help realize its potential. The grant, totaling more than 14 million hours of compute time, is provided through the Huang Foundation's partnership with CoreWeave using NVIDIA GPUs.

Training doctors in rural and remote communities and embedding First Nations knowledge and leadership in medical education could be key to improving healthcare access and workforce sustainability in Australia, the United States and other underserved communities worldwide.

A new review in Infectious Diseases & Immunity brings together the evidence on how hantavirus infection affects the mouth and saliva. A severe sore throat lasting 2 to 3 weeks can be an early sign; very low platelet counts raise the risk of oral bleeding, and saliva shows promise as a non-invasive testing sample. For Andes virus, the only hantavirus known to spread between people, infectious virus has been recovered from saliva and gum fluid, so dental teams in endemic regions, and those seeing returning travelers, should know the signs and take sensible precautions.

Four in five parents say it costs too much to have a baby, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.

ViVac Pharma has been named the winner of the 2026 Asper Prize for “The Hebrew University Rising Startup,” receiving the competition’s top honor and a NIS 100,000 award. Led by ASPER-HUJI Innovate in partnership with the Asper Foundation, the annual competition celebrates outstanding startups emerging from the Hebrew University community and highlights the University’s growing role in advancing entrepreneurship, innovation, and real-world impact.

Clinical trials play a vital role in progress against breast cancer. As part of the National Clinical Trials Network sponsored by the National Cancer Institute, the Alliance for Clinical Trials in Oncology works to advance cancer research and expand access to promising screening strategies and treatments. Through its clinical trials, the Alliance helps generate the evidence needed to improve care and bring better treatment options to patients. Today, the Alliance and Alliance Foundation Trials (AFT) have eight active trials open to people with breast cancer. Each represents another opportunity to advance research, improve care, and shape the future of breast cancer treatment.

The winners of the Applied Microbiology International Horizon Awards 2026 have been announced. 

The prizes, awarded by the learned society Applied Microbiology International (AMI), celebrate the brightest minds in the field and promote the research, group, projects, products and individuals who continue to help shape the future of applied microbiology.